Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study of AG1549 in Combination With Viracept (Nelfinavir Mesylate) and Combivir (Zidovudine + Lamivudine) in Treatment-Naive HIV-Infected Patients
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Capravirine (Primary) ; Lamivudine/zidovudine (Primary) ; Nelfinavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 13 Oct 2005 New trial record.